Evidence map›Paper›PMID 34999960›Full record

ArticleJournal of neurology2022

Hearing abnormalities in multiple sclerosis: clinical semiology and pathophysiologic mechanisms.

Roberto A Cruz, Thomas Varkey, Ana Flavia, Ana Paula Amatuzzi Samways, Alejandro Garza, Gabrielle Greenlee, Margaret Friess, Jayne Sconzert, Afaf Aijaz, Walter Arruda and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Roberto A CruzDepartment of Neurology, Doctor's Health at Renaissance Health Neurology Institute, Austin, USA.
Thomas VarkeyDell Medical School, University of Texas at Austin, Austin, USA.
Ana FlaviaKent State University (KSU), Pontifícia Universidade Católica do Paraná (PUR-PR), Curitiba, Brazil.
Ana Paula Amatuzzi SamwaysThe Frohman Foundation, Austin, TX, USA.
Alejandro GarzaThe Frohman Foundation, Austin, TX, USA.
Gabrielle GreenleeThe Frohman Foundation, Austin, TX, USA.
Margaret FriessThe Frohman Foundation, Austin, TX, USA.
Jayne SconzertThe Frohman Foundation, Austin, TX, USA.
Afaf AijazThe Frohman Foundation, Austin, TX, USA.
Walter ArrudaDepartment of Internal Medicine, Universidade Federal do Parana, Curitiba, PR, Brazil.
Juliana KhouriDepartment of Neurology, Nossa Senhora das Graças Hospital, Curitiba, PR, Brazil.
Kent EllingtonDepartment of Neurology, Dell Medical School, University of Texas at Austin, Austin, USA.
Teresa C FrohmanThe Frohman Foundation, Austin, TX, USA.
Elliot M FrohmanThe Frohman Foundation, Austin, TX, USA. Elliot.frohman@austin.utexas.edu.ORCID http://orcid.org/0000-0002-0674-8680
The University of Texas at Austin · USDow University of Health Sciences · PKGrand Canyon University · USHospital Nossa Senhora das Graças · BRPontifícia Universidade Católica do Paraná · BRStanford University · USThe University of Texas Rio Grande Valley · USUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Auditory manifestations from multiple sclerosis (MS) are not as common as the well-recognized sentinel exacerbations of optic neuritis, partial myelitis, motor weakness, vertiginous episodes, heat intolerance, and eye movement abnormalities. This paper discusses four cases of auditory changes, secondary to MS, and describes the first case, to our knowledge, of palinacousis, the perseveration of hearing, despite cessation of the sound stimulus. For each we characterize the initial complaint, the diagnostic work up, and ultimately, underscore the individualized treatment interventions, that allowed us to achieve a remission in all four cases. Individually codifying the treatment regimens served to mitigate, if not to abolish, the clinical derangements in hearing. Special attention is focused upon examination of the clinical manifestations and the pathophysiologic mechanisms which are responsible for them. We further emphasize the differential diagnostic considerations, and physical exam findings, along with the results of laboratory testing, neuro-imaging sequences, and lesion localization. Taken together, such information is germane to organizing cogently coherent strategic treatment plan(s). We believe that this small case series represents a clinically pragmatic example of 'precision medicine'; a principal theme and goal throughout this paper, the achievement of such in MS, but also as an illustration for the assessment and management schema for neuroimmunologic disorders in general.

Indexed as

Multiple SclerosisAcoustic StimulationAuditory PathwaysHearingHumansAuditory nucleiBrodmann area 41Cranial nerve VIIIHeschl’s gyrusInferior colliculusLateral lemniscusMedial geniculate nucleusMultiple sclerosisPalinacousisSensorineural hearing lossSuperior temporal gyrusTrapezoid body

Identifiers

PMID34999960
OpenAlexW4206835400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.